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Abstract
The enzyme-linked immunosorbent assay (ELISA) technique is based on the specific recognition ability of the molecular structure
of an antigen (epitope) by an antibody and is likely the most important diagnostic technique used today in bioscience. With this
methodology, it is possible to diagnose illness, allergies, alimentary fraud, and even to detect small molecules such as toxins, pesti-
cides, heavy metals, etc. For this reason, any procedures that improve the detection limit, sensitivity or reduce the analysis time
could have an important impact in several fields. In this respect, many methods have been developed for improving the technique,
ranging from fluorescence substrates to methods for increasing the number of enzyme molecules involved in the detection such as
the biotin–streptavidin method. In this context, nanotechnology has offered a significant number of proposed solutions, mainly
based on the functionalization of nanoparticles from gold to carbon which could be used as antibody carriers as well as reporter en-
zymes like peroxidase. However, few works have focused on the study of best practices for nanoparticle functionalization for
ELISA enhancement. In this work, we use 20 nm gold nanoparticles (AuNPs) as a vehicle for secondary antibodies and peroxidase
(HRP). The design of experiments technique (DOE) and four different methods for biomolecule loading were compared using a
rabbit IgG/goat anti-rabbit IgG ELISA model (adsorption, directional, covalent and a combination thereof). As a result, AuNP
probes prepared by direct adsorption were the most effective method. AuNPs probes were then used to detect gliadin, one of the
main components of wheat gluten, the protein composite that causes celiac disease. With this optimized approach, our data showed
a sensitivity increase of at least five times and a lower detection limit with respect to a standard ELISA of at least three times. Addi-
tionally, the assay time was remarkably decreased.
Beilstein J. Nanotechnol. 2017, 8, 244–253.
245
Introduction
Enzyme-linked immunosorbent assay (ELISA) is a technique
based on the ability of antibodies to bind specifically to an
antigen and has been used for more than 55 years [1]. Nowa-
days, it is the most commonly used technique for routine moni-
toring and analysis [2,3]. Initially, the antigen–antibody interac-
tion was monitored by means of radioactive species, but soon
these methods were replaced by easier to read and safer enzy-
matic systems, where is peroxidase (HRP) the most commonly
used reporter enzyme due its stability and performance [2-4].
The success of ELISA relies on its detection limit, specificity,
reproducibility and the possibility of high throughput screening,
although the assay normally takes several hours to develop the
response [3].
Despite all the advantages, the sensitivity of ELISA for certain
systems is limited [5], pointing to the need for novel strategies
that could improve the ELISA limit of detection (LOD). Some
strategies have been explored to enhance sensitivity, such as
redox complexes, electroactive molecules and metal ions [6].
Along these lines, several nanotechnology-based strategies have
been proposed involving nanoparticle-based solutions [5,7-12].
Nanoparticles can serve as excellent carriers for specific recog-
nition molecules such as antibodies or probes as well reporter
molecules. Due to their high surface/volume ratio, they present
more binding sites for capture elements and for reporting tags
leading to amplification of the analytical signal in a single
recognition reaction [6,8]. Luo and co-workers showed better
sensitivities and shortened times for the detection of C-reactive
proteins by using a quantum-dot-labeled immunoassay [13].
Accordingly, an improvement in sensitivity of 5,000 times for
the detection of the ataxia telangiectasia mutated protein by
functionalized multiwalled carbon nanotubes was observed by
Zhang et al. [7].
However, the most significant improvements in signal have
been rendered by gold nanoparticles (AuNPs), presenting prom-
ising unique chemical and physical properties, as well as bio-
logical compatibility [5,14,15]. AuNPs possess the advantages
of easy synthesis and narrow size distribution together with an
easy and efficient surface modification compatible with linkers
or biomolecules [16].
A critical step for obtaining gold complexes is the conjugation
of biomolecules to AuNPs. Increasingly, the process of loading
biomolecules to the nanoparticle surface it is considered more
important, as its properties or biochemical activity can be
changed. It was shown that several parameters such as surface
chemistry, pH, stabilizing agents as well as addition procedure
strongly affect final coverage and efficiency of biomolecules
[17,18]. Moreover, the AuNP–biomolecule binding can be com-
pleted by different procedures. Biomolecules can be simply
adsorbed on the nanoparticle surface by means of electrostatic
or hydrophobic interactions, leading to a high number of pro-
teins per particle and random orientation of biomolecules
[8,12]. Other studies reported more stable covalent immobiliza-
tion, where a better control of particle coverage is achieved and
even the binding orientation can be controlled [19-21]. Each of
the described procedures present advantages and disadvantages
such as leakage of non-covalently attached biomolecules or loss
of biomolecule activity due to aggressive protocols [22,23].
Thus, an optimal conjugation strategy will depend on the final
application. To the best of our knowledge, there are no specific
studies on the effect of conjugation strategy on the potential of
gold complexes to improve ELISA sensitivity. Hence, the main
objective of this work is to compare, under similar conditions,
different functionalization strategies in order to know which one
is the best approach for this kind of application.
In this work, a simple model for detection of rabbit IgG by
AuNPs conjugated to goat anti-rabbit IgG (Ab) and HRP
(AuNPs-Ab-HRP) was assayed to elucidate the best conditions
for biomolecule binding and ELISA enhancement. We explored
the effect of four different described procedures for binding
antibodies and HRP to AuNP surfaces in order to enhance
ELISA sensitivity. Afterwards, the strategy which demon-
strated better sensitivity was used for detection of gliadin from
wheat gluten, one of the main proteins of wheat gluten [24].
Gluten refers to a group of proteins contained in wheat, barley
and rye and is thought to be the cause of celiac disease (CD).
CD is an autoimmune enteropathy that causes mucosal damage
in the small intestine, leading to malabsorption upon intake of
gluten containing food [25]. Consequently, it is essential to use
a highly sensitive and specific technique for gluten analysis in
food. Nowadays, the method internationally accepted by the
Codex Alimenatarious Comission is the sandwich ELISA assay
[24]. Therefore, any strategy that could improve the detection
limit generates considerable interest.
Results and Discussion
Conjugation of anti-rabbit IgG and HRP to
AuNPs by direct adsorption and directional
conjugation
The aim of this work is to compare different AuNP functionali-
zation methods in order to know which one is the best for
enhancing the ELISA signal (Figure 1). As a first approach, two
different strategies for conjugation of proteins to nanoparticles
were evaluated: adsorption of biomolecules on nanoparticles by
electrostatic/hydrophobic interactions or directional binding by
means of a linker (Figure 1a,b).
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Figure 1: Schematic representation of the four different functionalization methods explored in this work. (a) Direct adsorption. (b) Directional conjuga-
tion with control of antibody and HRP orientation. (c) Covalent conjugation through antibody and HRP amine groups. (d) Combination of directional
and adsorption strategy for antibody and HRP.
For the first one (adsorption), a protocol was set up regarding
previous work on the matter [8,26]. In the case of the direc-
tional strategy, a previously described protocol was followed
[20]. A hetero-bifunctional linker, hydrazide-polyethylene
glycol-dithiol, was used to control the orientation of the mole-
cules on the surface of the nanoparticle. Hydrazide is able to
react with aldehyde groups that can be generated by oxidizing
the carbohydrates of glycosylated proteins, such as antibodies
[20]. For this purpose, antibody and HRP carbohydrates were
oxidized with periodate in order to attach the mentioned linker
at the Fc region of the antibody. Modified HRP and antibodies
were mixed with the AuNPs, triggering a covalent binding.
HRP/Ab ratio optimization for direct
adsorption and directional conjugation
In order to elucidate the best conditions for nanoparticle and
biomolecule assembly, the HRP/Ab molar ratio is known to be
one of the most influential parameters in AuNP complexes as
well as the probe concentration [6,8,12]. Furthermore, to cover
all the possible combinations of parameters, while keeping the
number of calculations to a minimum, a design of experiments
technique (DOE) [27] was applied. Through DOE, the influ-
ence of the HRP/Ab ratio and AuNP concentration on ELISA
performance can be easily studied. The DOE experiment was
performed using different ratios between HRP and goat anti-
rabbit IgG (1:5, 1:40 and 1:75 HRP/Ab) to elucidate the best
conditions for the two functionalization strategies evaluated,
that is, direct adsorption of biomolecules and directional
assembly. These conjugates were evaluated with a fixed con-
centration of rabbit IgG (1 µg/mL) coated in a microplate well.
Moreover, the influence of AuNP probes at different dilutions
was also considered. For each HRP/Ab ratio, three different
concentrations of AuNP probes (0.05, 0.4 and 0.75 AU) were
assayed. The results were evaluated in terms of percent with
respect to maximal signal at 450 nm. As a result, optimized
ratios of 1:57 and 1:44 were obtained for the adsorption and
directional methods, respectively (Figure 2).
These ratios are close to similar works performed with carbon
nanotubes and covalent conjugation of HRP and anti-IgG,
where an optimal ratio of 1:50 HRP/Ab was also found [7].
However, they differ from the work of Zhou and coworkers,
which was developed using 20 nm AuNPs and a direct adsorp-
tion strategy, where they found 1:6 as the optimal ratio for
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Figure 2: DOE experimental results for adsorption (a) and directional (b) methods. Estimation of the effect on response of HRP/Ab ratio and AuNP
probe concentration. The layout displays the response value as percent of the maximal HRP signal at 450 nm. Coefficient of determination of DOE
results R2 = 0.9485 (a) and R2 = 0.9768 (b).
HRP/Ab [8]. A similar ratio (1:3) was selected by Wu et al.
when modifying 15 nm AuNPs for the detection for Samonella
typhimurium [5]. These differences could be due to longer incu-
bation times in the mentioned references, around 3 and 24 hours
respectively, compared to 1 hour applied in our protocols. In ad-
dition, the ratios HRP/Ab assessed by these authors are lower
than the ones considered in our work. Besides the dissimilar
procedures employed, it is described that different variations in
ionic strength, pH, protein order addition, as well as the
inherent protein properties may modify the amount of biomole-
cules bound to the nanoparticle surface [17,21,28]. In this study,
where two different biomolecules meet at the AuNP surface, the
surface chemistry, different affinities towards gold and the
microenvironment may have a great influence on the antibody
nature and affinity for the antigen. This underlines the need of a
simultaneous comparison between different strategies in
order to obtain the most suitable protocol for this particular ap-
plication.
On the other hand, as mentioned, the concentration of gold
complexes must be taken into account for enhancing the ELISA
signal. Therefore, in DOE experiments the influence of increas-
ing the AuNP concentration (0.05, 0.4 and 0.75 AU) was also
assessed. As seen in Figure 2, the increase of AuNPs results in a
better performance up to the concentration assayed. Thus, as a
first approach, a concentration of 0.5 a.u. AuNPs was applied in
the ELISA characterization. Nevertheless, the influence of com-
plex dilution was further assayed with the selected functionali-
zation strategy.
Adsorption and directional strategies:
comparison by ELISA
Conjugates were assayed by ELISA using rabbit IgG as the
target. In all cases, AuNP probes were compared to a regular
anti-rabbit IgG HRP conjugated antibody (Ab-HRP) to compare
the sensitivity reached with the different methodologies
(Figure 3a,b). Accordingly, the results were evaluated in terms
of signal/noise (S/N) which represents the absorbance at
450 nm of samples in the presence and absence of IgG, respec-
tively. The S/N ratio of samples conjugated by adsorption
showed a higher response than directional conjugates or
Ab-HRP. This was an unforeseen result, as better efficiency
was expected due the directional conjugation, where more
antigen-binding sites on the fragment antigen-binding (Fab)
portion of the antibody are directed outward from the gold sur-
face and therefore available for antigen binding [19-21]. Perio-
date is widely used for HRP conjugation to biomolecules
[2,29,30]. For this reason, we considered it appropriate to
follow the protocol of Kumar et al. [20] for directional functio-
nalization of AuNP with Ab and HRP. However, this kind of
protocol may cause partial enzyme denaturation, as periodate is
a powerful oxidant and could decrease HRP activity to a great
degree [2].
New biofunctionalization strategies with
covalent and directional/adsorption:
comparison by ELISA
As described above, we decided to evaluate two other new ap-
proaches (Figure 1c,d). One approach is covalent conjugation,
where antibodies and HRP are covalently bound to the surface
by the means of a PEG linker through its free amine groups
using the EDC/NHS carbodiimide method [30]. The second is a
merge of the previously assayed procedures, combining the
directional binding of the antibody with the adsorption of the
HRP to the AuNP surface (directional and adsorption proce-
dure). For the covalent strategy we set up the conjugation pro-
cedure according to previous works [19] and the DOE results.
In the case of the directional/adsorption procedure, the protocol
for directional Ab loading and concentration of HRP from
adsorption method were applied.
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Figure 3: (a) Schematic representation of model ELISA and the basis of enhancement by means of AuNP probes. (b) Result of ELISA comparing
AuNP probes prepared by adsorption (red curve), directional conjugation (green) and labelled secondary antibody (Ab-HRP, blue). (c) Result of
ELISA comparing AuNP probes prepared by adsorption (red), covalent (orange), directional and adsorption (purple) and Ab-HRP (blue). Results are
represented as the S/N ratio which represents the absorbance at 450 nm of samples in the presence and absence of IgG, respectively.
Consequently, ELISA was assessed for comparing the new pro-
posed strategies as well as the direct adsorption that already
yielded good results (Figure 3c). Once more, adsorption conju-
gation resulted in better S/N response than the Ab. Surprisingly,
new conjugation strategies (covalent and directional/adsorption)
resulted in worse S/N values than direct adsorption and even
more than Ab-HRP, although it is described that covalent and
site specific immobilization leads to more stable and better
defined composition conjugates [19,20,31]. In an attempt to
better understand these data, it was found that the HRP mole-
cule (Uniprot accession number P80679) presented a lower
number of free amine groups (few lysine amino acid residues)
compared to the antibody molecule. The lower availability of
free amino groups could hamper the attachment of peroxidase
in the covalent strategy (Figure 1c), although more experiments
should be performed to confirm this. Consequently, this would
lead to lower peroxidase coverage and thus lower ELISA en-
hancement. The combination of the directional and adsorption
strategy would be presented as best alternative according to this
hypothesis, however, ELISA experiments showed a low S/N
ratio compared to other methodologies. The combined strategy
implies a two-step functionalization, where the antibody is first
directionally bound to the surface, and secondly, HRP is added
for a direct adsorption loading. The sequential procedure
inevitably signifies less free binding sites on the nanoparticle
surface after the first step. It was previously described how the
arrangements of biomolecules can affect complex coverage and
behavior [17]. Moreover, Marie-Eve Aubin-Tam and coworkers
showed how ligand charges around the particle can strongly in-
fluence protein structure, and therefore, activity [32]. Both
factors would indicate lower peroxidase coverage/activity in
this functionalization strategy.
In contrast, direct adsorption often leads to protein multilayers,
as biomolecules have numerous residues which can non-specifi-
cally adsorb on AuNP surfaces [33]. Gagner et al. described
how high protein loading resulted in lower loss of protein activ-
ity and secondary structure [34]. They assumed that subsequent
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adsorption of protein in multilayers allowed the conjugate to
recover activity and remain stable. Taking into account the
published results and considering our data, we postulated that
the total number of proteins bound to AuNPs could probably be
higher by the direct adsorption method than for the others
strategies, resulting in lower protein denaturation and a higher
S/N ratio.
Optimization of AuNP concentration in ELISA
Once the best functionalization strategy (adsorption) was
defined, the influence of the concentration of the complex was
probed in an ELISA model. As described above (Figure 2), the
higher AuNP concentration, the higher the signal. Accordingly,
this hypothesis was checked with four different concentrations
of AuNP conjugates: 0.25, 0.5, 0.75 and 1.00 a.u. (Figure 4).
Figure 4: Optimization of AuNP probe concentration to be used in
ELISA. Assayed concentrations: 0.25, 0.5, 0.75 and 1.00 Au. Results
are normalized as S/N ratio which represents the absorbance at
450 nm of samples in the presence and absence of IgG, respectively.
In fact, it was confirmed that the higher concentration of
AuNPs, the higher the S/N. However, it was expected that
doubling the concentrations of the conjugates (i.e., from 0.5 a.u.
to 1 AU) would result in an increase of S/N. This effect was not
observed, where the concentrations of 0.75 a.u. and 1 a.u. pro-
duced only an increase of 9% and 23% S/N in ratio at 200 ppb
of IgG. Additionally, the concentration of 1 a.u. induced a
higher unspecific signal. The best balance between high sensi-
tivity and reduced utilization of AuNP probes, as well as low
unspecific signal, was found at a concentration of 0.5 a.u. More-
over, this result is consistent with the literature, as published by
Ambrosia and co-workers in studying the effect of AuNP com-
plexes in enhanced ELISA for the detection of breast cancer
biomarkers [12]. In this work, the authors assessed three differ-
ent concentrations of AuNP probes (ranging approximately
from 1.4 to 0.014 AU) discarding the highest and lowest con-
centrations due to unspecific signal and low signal enhance-
ment, respectively.
Enhanced gliadin ELISA
Once defined as the best strategy for ELISA enhancement of
IgG/anti-IgG for conjugation of AuNPs to Ab, the adsorption
method was tested for the detection of a real analyte, namely,
gliadin. Gliadin (which can be also subdivided into α-gliadin,
γ-gliadin and ω-gliadin) is a prolamin protein present in wheat
gluten and one of the presumed causes of celiac disease [24].
The official detection method by Codex Alimenatarius
Commission is a sandwich ELISA assay. For this reason, it was
selected as a proof-of-concept for improving the detection limit
based on AuNPs conjugates and application to commercial
rabbit polyclonal antibody (anti-gliadin).
An indirect ELISA was selected for the analysis (reference),
where gliadin was coated on the ELISA plate at different con-
centrations (0–1 µg/mL dilutions 1:5) (Figure 5). After
blocking, the primary antibody for gliadin was added at the
supplier’s recommended dilution (1:5,000). Subsequently, the
secondary antibody (Ab-HRP or AuNPs probes) was added at
optimal dilution (i.e., 1:10,000 for commercial antibody and
0.5 a.u. for AuNPs conjugates) and recorded signals were com-
pared. As seen in Figure 5, enhanced ELISA provides a higher
signal, therefore improving the sensitivity, and also the detec-
tion limit.
The enhanced procedure resulted in more than seven times
higher S/N values at 1 × 106 pg/mL than regular ELISA. The
LOD, estimated as the blank signal plus three times the blank
standard deviation, reveals a theoretical LOD near 180 pg/mL
for this enhanced ELISA, whereas conventional ELISA presents
a theoretical LOD close to 500 pg/mL. The improvement of
three times the LOD is similar to other works using the same
functionalization strategy (adsorption) and 20 nm AuNPs
[8,12]. Moreover, it should be pointed out that only a 5 min
incubation with 3,3’,5,5’-tetramethylbenzidine (TMB) is needed
to reach a measurable and even saturated signal (depending on
target concentration), while classical ELISA often requires at
least 30 min to develop the color. Therefore, this enhanced
strategy could help not only for improving the sensitivity and
detection limit of ELISA performance, but also for decreasing
the ELISA assay time as other authors have proposed [35]. This
extended assay time is recognized as one of the major handi-
caps nowadays of the ELISA assay [3]. In addition, this im-
proved methodology has the potential for improving the detec-
tion of other target antigens by indirect ELISA, as AuNPs are
functionalized with a universal goat secondary antibody.
Another possibility is to use this method in direct ELISA by
conjugating primary antibodies and HRP on AuNPs. Many of
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Figure 5: Schematic representation of gliadin detection by indirect ELISA and the basis of enhancement by means of AuNP probes. (Inset) Result of
gliadin ELISA comparing AuNP probes prepared by adsorption (red curve) and Ab-HRP (blue). Results are represented as S/N ratio which repre-
sents the absorbance at 450 nm of samples in the presence and absence of IgG respectively. Coefficient of determination R2 = 0.9968 for AuNP
probes and R2 = 0.7971 for Ab-HRP. Note that assayed concentrations are around the theoretical LOD of Ab-HRP.
the allergen determinations by ELISA use this strategy, but
more research on this is necessary to confirm this.
Conclusion
In summary, our main objective at the start of the work was to
elucidate whether a covalent loading or directional binding of
biomolecules on AuNPs could lead to better results than simple
direct adsorption for an enhanced ELISA application. For this
purpose, four different functionalization methods of AuNPs
with HRP and goat anti-rabbit IgG were used in order to en-
hance the ELISA sensitivity with respect to regular ELISA. The
synthesized AuNPs probes were assessed in model rabbit IgG
and anti-rabbit IgG ELISA by comparing the colorimetric S/N
ratio. The direct adsorption method prevails as the better option
with respect to the other methodologies due its performance,
presenting in addition an easier preparation (no chemical steps
are needed). This method was applied for improving gliadin
detection by indirect ELISA. The application of AuNP probes
reduced the theoretical LOD to 180 pg/mL, which is three times
lower than regular ELISA, and led to an increase of at least
seven times in sensitivity at level of 1 × 106 pg/mL. This
strategy could help to shorten ELISA assay times, making it
less time consuming as well as increasing sensitivity and the
LOD of the experiment. In addition, this methodology could be
extended to other ELISA systems where a secondary labelled
antibody is needed. Moreover, it could be a suitable methodolo-
gy for combining primary antibodies with HRP, avoiding
tedious chemical labelling procedures.
Experimental
20 nm gold nanoparticle synthesis
All glassware was cleaned with aqua regia (HNO3/HCl, 3:1),
rinsed with deionized water and let dry before use. 20 µL of
30% HAuCl4·3H2O was added to 95 mL of deionized water in a
100 mL flask and heated to boiling under vigorous stirring.
5 mL of 1% aqueous sodium citrate was added to the solution,
changing color from yellow to dark red. The nanoparticles were
maintained at boiling for 15 min after the complete color
change and then removed from heat. Stirring was maintained
until the flask reached room temperature. AuNPs and conju-
gates were characterized by dynamic light scattering (DLS)
using a zeta potential analysis system (Zetasizer Nano Z,
Malvern Instrumentd, Worcestershire, UK), field emission
scanning electron microscope (Carl Zeiss) and UV–vis spec-
trophotometer (Supporting Information File 1, Figure S1).
Gold nanoparticle functionalization
Four different strategies were assayed in this work and are
schematized in Figure 1. For the direct adsorption functionaliza-
tion, 133 μL of 15 mM borate buffer pH 8.7 were added to
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1 mL of AuNPs synthetized as described above to adjust the
pH. The appropriated amount of goat anti-rabbit IgG and horse-
radish peroxidase were added and allowed to react under agita-
tion in a carrousel for 30 min. Afterwards, sucrose was incorpo-
rated to a final concentration of 5% and incubated for 30 min.
Finally, 160 μL of 3% bovine serum albumin (BSA) were added
and shaken for 10 min. Thereafter the sample was centrifuged
(7,500g 30 min) to remove unbound protein and AuNPs were
re-suspended in 1 mL of 2 mM borate buffer pH 8.7 containing
5% sucrose, 2% glycerol, 0.5% BSA, and 0.01% Tween. The
washing step was repeated once and the AuNP probe was
re-suspended in 100 μL of the mentioned borate buffer. The
complex concentration was measured by absorption at 520 nm
and kept at 4 °C until use.
For the directional functionalization, the protocol of Kumar and
co-workers was followed with slight modifications [20]. Anti-
rabbit goat IgG (Ab) and HRP were oxidized with periodate and
incubated with the linker hydrazine dithiol. Briefly, 100 μL of
Ab 1 mg/mL was incubated with 30 μL of 100 mM phosphate
pH 7.4 and 10 μL of periodate 100 mM protected from light for
30 min. In the case of peroxidase, 200 μL of HRP 3 mg/mL
were incubated with 20 μL of periodate 100 mM protected from
light for 20 min. After these incubation times, 500 μL of PBS
were added respectively to quench the reaction. Thereafter,
1.97 μL of 23.5 mM linker hydrazine dithiol were added and
mixed for 2 h at room temperature protected from light. The
proteins were buffer exchanged against phosphate buffer
10 mM pH 7.4 using a Hi-Trap desalting column using an Äkta
Prime apparatus (GE-Healthcare, Upsala, Sweden). The
Ab-linker and HRP-linker concentrations were measured by
absorption at 280 nm and 403 nm, respectively, as well as by
Bradford assay (data not shown). Afterwards, the appropriated
amount of Ab-linker and HRP-linker were mixed with 1 mL of
AuNPs and incubated for 20 min. Thereafter, 100 μg of m-PEG
thiol were added and mixed again for 20 min. Subsequently,
100 µL of 1 mg/mL of BSA were incubated for 10 min more.
Samples were centrifuged (5,000g 30 min) and re-suspended in
1 mL phosphate buffer 10 mM pH 7.4 containing 0.5% BSA
and 0.01% Tween 20. This step was repeated twice but after the
last wash, the complex was re-suspended in 400 µL. The com-
plex concentration was measured by absorption at 520 nm and
kept at 4 °C until use.
In case of the directional/adsorption functionalization, the
protocol of both methods was followed with some modifica-
tions. Briefly, to 1 mL of synthesized AuNPs, 133 µL of 15 mM
borate buffer pH 8.7 were added to adjust the pH. Then, the
appropriate amount of Ab-linker was added to reach a final con-
centration of 2.25 ppm and the solution was mixed for 20 min at
room temperature. After antibody incubation, the sample was
mixed with nonmodified HRP to a final concentration of
144 ppm and shook for 20 min. Thereafter, sucrose (5%), BSA
(0.5%), and Tween 10 (0.01%) were added to assure complex
stability. The mixture was allowed to react for 10 min and puri-
fied by centrifugation at 7,500g for 30 min. The AuNP probe
was re-suspended in 1 mL of borate buffer pH 8.7 containing
5% sucrose, 2% glycerol, and 0.01% Tween. The washing step
was repeated once and the complex was re-suspended in 100 μL
of mentioned buffer. The complex concentration was measured
by absorption at 520 nm and kept at 4 °C until use.
Covalent functionalization was achieved using hetero-bifunc-
tional linkers of polyethyleneglycol (PEG). In this case, AuNPs
were incubated overnight with methyl-PEG-thiol (mPEG thiol,
n = 6) and PEG-thiol acid (n = 7) in order to create a mixed
monolayer of linker on the nanoparticle. 1 mL containing
0.075 M of mPEG thiol and 0.025 M of PEG-thiol acid was
added to 100 mL of synthetized AuNPs and maintained
overnight under stirring. Subsequently, the AuNPs were washed
by centrifugation at 18,000g for 30 min and the obtained pellet
was re-suspended in a smaller volume of water to arrive at a
concentration factor of approximately ×30. The conjugation to
antibody and peroxidase was achieved by applying the carbo-
diimide method to carboxylic groups of PEG-thiol acid [30].
Accordingly, 750 µL of AuNPs-PEG where added to 750 µL of
a mixture of EDC/NHS 40/20 mM and incubated for 30 min at
room temperature. Thereafter, AuNPs were centrifuged at
18,000g for 30 min and re-suspended in 1,500 µL of a solution
containing 25 ppm Ab and 440 ppm HRP in borate buffer
pH 8.7 and incubated for 4 h at room temperature. Finally,
AuNP-Ab-HRP complexes were washed twice at 18,000g for
30 min and re-suspended in 300 µL Tris-HCl 20 mM pH 8.8
20% glycerol and 1% BSA. The complex concentration was
measured by absorption at 520 nm and kept at 4 °C until use.
In all cases, the incubation of the proteins with AuNPs was
made at room temperature stirring the mixture in a carrousel.
Design of experiments
To build the design of experiments (DOE) matrix, some
conjugations of AuNPs with antibody and HRP and simple
ELISA assays were developed. For this, samples were functio-
nalized at different ratios of HRP/Ab (1:5, 1:40, 1:75) accord-
ing to the adsorption and directional procedure described above.
96-Multiwell plates were coated with a fixed concentration of
rabbit IgG (1 μg/mL) 1 h at 37 °C in 10 mM carbonate buffer
pH 9.6. Afterwards, these plates were washed one time with
phosphate buffer saline (PBST, 0.5% Tween 20), blocked with
1% BSA in PBST and incubated with the different samples of
AuNP probes for 30 min. For each HRP/Ab ratio, three differ-
ent concentrations of AuNP probes (measured as the absor-
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bance at 520 nm) were assayed, 0.05, 0.25 and 0.50 absorbance
units (AU). Subsequently, the plates were washed three times
with PBST and 100 μL of HRP substrate were added (TMB
0.1 mg/mL, 0.006% H2O2 in 40 mM pH 5.5 citrate buffer).
After 15 min at room temperature, the reaction was stopped by
adding 50 µL of 4 N H2SO4 and the absorbance was measured
at 450 nm in a Synergy Mx microplate reader from Biotek.
The results were used to build a surface-of-response graphic
and to determine the best HRP/Ab ratio and probe concentra-
tion in order to optimize the ELISA using DOE pro XL 2010
software from Microsoft.
ELISA rabbit IgG probed by goat
anti-IgG-HRP and AuNP conjugates
The ELISA plate was coated using different rabbit IgG concen-
trations (ranging 0–1 µg/mL) in carbonate buffer 10 mM pH 9.6
for 4 h at RT or overnight at 4 °C. Then the plates were washed
three times with PBST and blocked using BSA 1% in PBST at
37 °C for 30 min. The plates were washed three times with
PBST and incubated with 100 µL of goat anti-rabbit IgG-HRP
conjugated (Ab-HRP, dilution 1:10,000) or AuNP probes
(AuNP-Ab-HRP) at the appropriate concentration at 37 °C for
30 min in buffer NaPi 10 mM pH 7.4, 0.5% BSA and 0.05%
Tween 20. The plates were washed four times with PBST and
incubated 5 min with HRP substrate. The reaction was stopped
by adding 50 µL of H2SO4 4 N and the absorbance was
measured at 450 nm in a microplate reader. For each step a
volume of 100 µL was used, except for the washing step where
300 µL were used. A curve log(agonist)–response was adjusted
to obtained data y = min + (max − min)/(1 + 10log(EC50 − X)).
ELISA gliadin probed by goat anti-IgG and
AuNP conjugates
The ELISA plate was coated using different gliadin concentra-
tions ranging from 0–1 µg/mL dilutions 1:5 in carbonate buffer
10 mM pH 9.6 4 h at RT. Then, the plates were washed three
times with PBST and blocked with BSA 1% in PBST at 37 °C
for 30 min. The plates were washed three times with PBST
and incubated with rabbit anti-gliadin antibody diluted
1:5,000 times in PBST for 30 min at room temperature. The
plate was washed three times with PBST and incubated with the
appropriated amount of anti-IgG-HRP (from now Ab-HRP,
dilution 1:10,000) or Au probes at 37 °C for 30 min in the
buffer NaPi 10 mM pH 7.4, 0.5% BSA and 0.05% Tween 20.
The plates were then washed four times with PBST and incubat-
ed for 5 min with HRP substrate. The reaction was stopped by
adding 50 µL H2SO4 4 N and read at 450 nm. For each step, a
volume of 100 µL was used, except for the washing step where
300 µL were used. A curve log(agonist)–response is adjusted to
obtained data y = min + (max − min)/(1 + 10log(EC50 − X)).
Materials
The BSA fraction VI for blocking was purchased from Merck.
ELISA Maxisorb plates were acquired from Nunc. The linker
PEG6-hydrazide aromatic dialkanedithiol was used for deriva-
tion of antibody and HRP in the directional conjugation and was
obtained from NanoScience Instruments. The linkers mPEG-
thiol (n = 6) and PEG-thiol acid (n = 7) for the covalent functio-
nalization were acquired from Polypure. Rabbit IgG, poly-
clonal goat anti-rabbit IgG, goat anti-rabbit IgG HRP conju-
gated, HRP type VI, gliadin from wheat gluten, rabbit anti-
gliadin and all other chemicals used were purchased from
Sigma-Aldrich.
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